Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: 5 - You Need To See This

AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment

Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site

The Guardian - UK

How TrumpRx drug prices compare to generic alternatives

Patients could save more buying non-branded copycat drugs, even if they don't have insurance.

Axios

‘You’ll save a fortune’: What is TrumpRx? All about Trump’s online drugstore plan

US President Trump's new TrumpRx website is rolling out, aiming to slash prescription drug costs by getting them straight from manufacturers. They're promising big savings on popular meds like weight-loss and fertility treatments, using a 'most favoured nation' pricing strategy. This is all about making healthcare more affordable for Americans,…

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy

The Independent UK

The new ‘blue pill’: Honey energy supplement under recall for having ED medicine mixed in

The affected ED drug may cause heart issues, blood pressure changes, dizziness and headaches, particularly in people with health conditions or taking certain medications

The Independent UK

GSK, take two: the bullish tone at the top is finally more convincing

New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential

The Guardian - UK

Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026

Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca to invest £11bn in China after rowing back on UK expansion

Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs

The Guardian - UK

Altria earnings fall short amid lower cigarette sales and competition for nicotine products

Shares of Altria dipped Thursday after the tobacco giant reported flat earnings due to declining cigarettes sales and challenging competition for newer products, including flavored nicotine pouches

The Independent UK

NovaDerm and Solidaris Capital: How Selective Narratives Obscure Regulatory Evasion and Charitable Tax Misuse

Solidaris markets itself as a socially responsible investment platform promising large deductions, but public records and whistleblower reports reveal significant operational discrepancies.

International Business Times

Police smash Europe-wide synthetic drug ring in biggest bust yet

A coordinated European police operation has dismantled a vast cross-border synthetic drug ring in what investigators hailed as the largest operation of its kind to date.

Radio France Internationale

The Incentive Problem in Healthcare and Jacob Fuchs's Journey to Fix It

As a pharmacist by training and a builder by instinct, Jacob Fuchs, founder of Premier Pharma, approaches healthcare with a systems-level mindset shaped by years of hands-on experience.

Medical Daily

GSK to buy food allergy drug maker RAPT in $2.2bn deal

US-based biotech firm is developing treatment for allergies to nuts, milk and eggs in children and adults

The Guardian - UK

EU Mulls Tariffs and Market Restrictions on US in Response to Greenland Threat

EU considers $108B in tariffs and market restrictions on the U.S. after Trump's Greenland threats, raising trade tensions.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times

The Independent UK

Generic Ozempic drugs are about to flood the market

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high prices

The Independent UK

British Columbia ending its 3-year drug decriminalization pilot project

Canada’s Pacific coast province of British Columbia is ending its three-year experiment in decriminalizing possession of small amounts of drugs

International Business Times

Reducing Injection Anxiety: Painless World Aims to Give Patients the Confidence to Inject at Home

From chronic disease management to fertility treatments and hormone therapies, millions of patients are now expected to administer injections at home rather than in clinical settings. The global self-injection devices market is expected to reach over $19 billion by 2030.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Revealed: the crypto entrepreneur linked to illegal weight-loss drug operation

Haul of illicit products led by medicines regulator was described as world’s largest of its kind, but no arrests have yet been made

The Guardian - UK

Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

First and only GLP-1 pill on the market costs significantly less than injectable versions

International Business Times UK

NHS Refuses to Fund Life-Saving Motor Neurone Disease Medication Despite Free Supply From Drugmaker

MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering administration costs.

International Business Times

US Drug Pricing Deal May Lead to Swiss Medicine Price Hikes

US drug price cuts may push up the cost of new medicines in Switzerland, Roche's CEO warns.

The Guardian - UK

PPE company linked to ex-Tory peer Michelle Mone goes into liquidation

PPE Medpro owes government £148m for supplying unusable personal protective equipment during Covid-19 pandemic

Evening Standard

PPE Medpro wound up after being ordered to pay £148m to Government

The decision could mean that the Government is unlikely to see most of the £148 million owed to it by the company.

The Guardian - UK

The UK’s pharma deal was vital – but the GSK boss is right about US dominance

It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.